Skip to main content
Have a personal or library account? Click to login
Effect of stilbene derivative on superoxide generation and enzyme release from human neutrophils in vitro Cover

Effect of stilbene derivative on superoxide generation and enzyme release from human neutrophils in vitro

Open Access
|Nov 2012

References

  1. Babior BM. (2000). Phagocytes and oxidative stress.33-44.
  2. Brennan ML, Hazen Sl. (2003). Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.353-359.
  3. Drabikova K, Nosaľ R, Jančinova V, Čiž M, Lojek A. (2002). Reactive oxygen metabolite production is inhibited by histamine and H1 antagonist dithiaden in human PMN leukocytes.975-980.
  4. El-Benna J, Dang PM, Gougerot-Pocidalo MA. (2008). Priming of the neutrophil NADPH oxidase activation role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.279-289.
  5. Cheng JC, Fanf JG, Chen WF, Zhou B, Yang L, Liu ZL. (2006). Structure-activity relationship studies of resveratrol and its analogues by the reactionkinetics of low density lipoprotein peroxidation.142-157.
  6. Grover JK, Vats V, Yadav SS. (2005). Pterocarpus marsupium extract (Vijayasar) prevented the alteration in metabolic patterns induced in the normal rat by feeding an adequate diet containing fructose as sole carbohydrate.414-420.
  7. Hasiah AH, Ghazali AR, Weber JFF, Velu S, Thomas NF, Inayat Hussain SH. (2011). Cytotoxic and antioxidant eff ects of methoxylated analogues on HepG2 hepatoma and Chang liver cells: Implications for structure activity relationship.138-144.
  8. Kim JS, Ha TY, Ahn J, Kim HK, Kim S. (2009). Pterostilbene from Vitis coignetiae protect H2O2-induced inhibition of gap junctional intercellular communication in the rat liver cell line.404-409.
  9. Klink M, Jastrzembska K, Bednarska K, Banasik M, Sulowska Z. (2009). Effect of nitrid oxide donors on NADPH oxidase signalling pathway in human neutrophils.692-702.
  10. Lastra CA, Villegas I. (2005). Resveratrol as an anti-infl ammatory and antiaging agent: Mechanisms and clinical implications.405-430.
  11. Mačičkova T, Drabikova K, Nosaľ R, Bauerova K, Mihalova D, Harmatha J, Pečivova J. (2010).eff ect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis.91-95.
  12. Mihalova D, Poništ S, Bauerova K, Nosaľ R, Jančinova V. (2010). Comparative study of two stilbene derivatives in the experimental rat model of arthritis based on evaluation of clinical parameters.A67.
  13. Mikstacka R, Rimando AM, Ignatowicz E. (2010). Antioxidant eff ect of transresveratrol, pterostilbene, Quercetin and their combination in human erythrocytes.57-63.
  14. Ovesna Z, Horvathova K. (2005). Structure-activity relationship of trans resveratrol and its analogues.450-455.
  15. Pan MH, Chang YH, Tsai ML, Lai CHS, Ho SY, Badmaev V, Ho CHT. (2008). Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages7502-7509.
  16. Paul B, Masih I, Deopujari J, Charpentier C. (1999). Occurence of resveratrol and pterostilbene in age-old darakchasava an ayurvedic medicine from71-76.
  17. Pečivova J, Mačičkova T, Lojek A, Gallova L, Čiž M, Nosaľ R, Holomaňova D. (2006). Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive imunity.160-163.
  18. Pečivova J, Mačičkova T, Lojek A, Gallova L, Čiž M, Nosaľ R, Holomaňova D. (2007).eff ect of carvedilol on professional phagocytes.86-92.
  19. Perečko T, Jančinova V, Drabikova K, Nosaľ R, Harmatha J. (2008). Structure efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene.802-805.
  20. Perečko T, Jančinova V, Drabikova K, Nosaľ R, Harmatha J, Šmidrkal J. (2009). Effect of pterostilbene on human neutrophil viability and activity.138
  21. Perečko T, Drabikova K, Račkova L, Čiž M, Podborska M, Lojek A, Harmatha J, Šmidrkal J, Nosaľ R, Jančinova V. (2010). Molecular targets of the natural antioxidant pterostilbene: eff ect on protein kinase C, caspase-3 and apoptosis in human neutrophils.84-90.
  22. Perečko T, Drabikova K, Nosaľ R, Harmatha J, Bauerova K, Mihalova D, Jančinova V. (2010 a). Inhibition of oxidant production in rat adjuvant arthritis with pterostilbene.A73-74.
  23. Remsberg CM,Yanez JA, Ohgami Y,Vega-Villa KR, Rimando AM, Davies NM. (2008). Pharmacometrics of pterostilbene. Preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity.: 169-179.
  24. Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, Duke SO. (2002). Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol3453-3457.
  25. Rimando AM, Suh N. (2008). Biological/chemopreventive activity of stilbenes and their eff ect on colon cancer.1635-1643.
  26. Satheesh MA, Pari L. (2006). The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes melitus in Wistar rats.1483-1490.
  27. Schneider JG, Alosi JA, McDonald DE, Mc Fadden DW. (2010). Pterostilbene inhibits lung cancer through induction of apoptosis.18-22.
  28. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V. (2001). Specifi c structural determinants are responsible for the antioxidant activity and the cell cycle eff ects of resveratrol.22586-22594.
  29. Šmidrkal J, Harmatha J, Buděšinska M, Vokač K, Zidek Z, Kmoničkova E, Merkl VR, Filip M. (2010). Modifi ed approach for preparing (E) stilbenes related to resveratrol, and evaluation of their potential immunobiological effects.175-186.
DOI: https://doi.org/10.2478/v10102-012-0012-7 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 71 - 75
Published on: Nov 9, 2012
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2012 Tatiana Mačičková, Jana Pečivová, Juraj Harmatha, Klára Sviteková, Radomír Nosáľ, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.